Protected magnesium alloys for bioresorbable stents

Patent metadata

Field	Value
Publication number	US-12427231-B2
Application number	US-202217941851-A
Country	US
Kind code	B2
Filing date	Sep 9, 2022
Priority date	Nov 6, 2014
Publication date	Sep 30, 2025
Grant date	Sep 30, 2025

Abstract

Biodegradable magnesium alloy implantable medical devices are protected to delay onset of corrosion, and thus biodegradability, or to corrode more uniformly. The protection allows for extended effective use of the devices while maintaining biodegradability. Examples of protective coatings include conversion coatings that at least partially remove exposed second phases from a surface of the magnesium alloy and coatings that provide a barrier between water and the surface of the magnesium alloy.

First claim

The invention claimed is:

1. A biodegradable frame for an implantable medical stent, the frame comprising:
a magnesium (Mg) alloy core;
a conversion coating that removes exposed secondary phases from a surface of the Mg alloy; and
a layer of pure magnesium over the conversion coating.

2. The biodegradable frame of claim 1 , wherein the conversion coating comprises a conversion coating selected from the group consisting of:
a hydrofluoric acid (HF) conversion coating; a conversion coating with acidic or basic solutions of Ce 3+ or Ce 4+ ;
a conversion coating with an acidic or basic solution comprising an inorganic magnesium precipitating agent; and
a conversion coating with an acidic or basic solution comprising an organic magnesium precipitating agent.

3. The biodegradable frame of claim 2 , wherein the conversion coating comprises a conversion coating with an acidic or basic solution comprising an inorganic magnesium precipitating agent, and wherein the inorganic magnesium precipitating agent is selected from the group consisting of a phosphate, a silicate, a permanganate, a hydrotalcite, a vanadate, a chromate and a Rare Earth ion other than a cerium ion.

4. The biodegradable frame of claim 2 , wherein the conversion coating comprises a conversion coating with an acidic or basic solution comprising an organic magnesium precipitating agent, and wherein the organic magnesium precipitating agent is selected from the group consisting of 4-(4-nitrophenylazo)-resorcinol, 8-hydroxy quinolone, and sodium dodecylbenzenesulphonate.

5. The biodegradable frame of claim 2 , wherein the conversion coating comprises an HF conversion coating.

6. A stent comprising the biodegradable frame of claim 1 .

7. A biodegradable tubular frame for an implantable medical stent, comprising:
a magnesium (Mg) alloy layer;
a first layer of pure magnesium;
a second layer of pure magnesium, and
a first conversion coating layer on the Mg alloy layer;
wherein the Mg alloy layer is between the first and the second layers of pure magnesium, and
wherein the first conversion coating layer is between the Mg alloy layer and the first layer of pure magnesium, and wherein the first conversion coating layer removes exposed secondary phases from a surface of the Mg alloy layer.

8. The biodegradable tubular frame of claim 7 , wherein the first layer of pure magnesium defines an inner layer of the tubular frame.

9. The biodegradable tubular frame of claim 8 , wherein the second layer of pure magnesium defines an outer layer of the tubular frame.

10. The biodegradable tubular frame of claim 7 , wherein the second layer of pure magnesium defines an outer layer of the tubular frame.

11. The biodegradable tubular frame of claim 7 , further comprising a second conversion coating layer on the Mg alloy layer, wherein the second conversion coating layer is between the Mg alloy layer and the second layer of pure magnesium, and wherein the second conversion coating layer removes exposed secondary phases from a surface of the Mg alloy layer.

12. A stent comprising the biodegradable tubular frame of claim 7 .

13. A biodegradable tubular frame, for an implantable medical stent, comprising:
a magnesium (Mg) alloy layer;
a conversion coating layer on the Mg alloy layer;
a first layer of pure magnesium; and
a second layer of pure magnesium;
wherein the Mg alloy layer is between the first and the second layers of pure magnesium, and
wherein the conversion coating layer is between the Mg alloy layer and the second layer of pure magnesium, and wherein the conversion coating layer removes exposed secondary phases from a surface of the Mg alloy layer.

Assignees

• Medtronic Vascular Inc

Inventors

• Pulugurtha Syamala Rani
• Allen Jeffrey
• Mitchell James
• Storment Christopher
• Mendelson Jill

Classifications

• C23C16/06

  characterised by the deposition of metallic material · CPC title

• A61L2420/02

  Methods for coating medical devices · CPC title

• A61L31/10

  Macromolecular materials · CPC title

• A61L31/084

  Carbon; Graphite · CPC title

• A61F2230/0069

  cylindrical · CPC title